Pyxis oncology stock prediction.

The current market capitalization of Pyxis Oncology, Inc. is $70.473.568.00. If we look at the share price of Pyxis Oncology, Inc. over the last year, we see that it reached a high of $6.92 and a low of $1.10. Pyxis Oncology, Inc.shares have had an EPS of $-2.56. Likewise, its dividend rate has been $, with a dividend yield of %.

Pyxis oncology stock prediction. Things To Know About Pyxis oncology stock prediction.

Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for Pyxis Oncology stock is $12, which predicts an increase of 674.19%. The lowest target is $7.00 and the highest is $15. On average, analysts rate Pyxis Oncology stock as a strong buy.Pyxis Oncology stock price prediction is an act of determining the future value of Pyxis Oncology shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Pyxis Oncology's future price could yield a significant profit.Cash Flows for Pyxis Oncology Inc (PYXS) from Operating Activities, Investing Activities, Financing Activities.Mar 22, 2023 · As of December 31, 2022, Pyxis Oncology had cash and cash equivalents (including restricted cash) of $180.7 million, which is expected to fund operations into the first half of 2025.

141.12%. Get the latest Pyxis Oncology Inc (PYXS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …

May 13, 2022 · As of May 13, 2022, the outstanding number of shares of Common Stock of Pyxis Oncology was 32,817,062. About Pyxis Oncology, Inc. Pyxis Oncology, Inc. is a multi-asset multi-modality company ...

Detailed statistics for Pyxis Oncology, Inc. (PYXS) stock, including valuation metrics, financial numbers, share information and more. Skip to main content. Log In Free Trial. ... The beta is 1.12, so Pyxis Oncology's price volatility has been higher than the market average. Beta (1Y) 1.12: 52-Week Price Change +0.66%: 50-Day Moving …Insiders have purchased a total of 1,855,020 PYXS shares in the last 24 months for a total of $5,152,402.54 bought. Which Pyxis Oncology insiders have been selling company stock? The following insiders have sold PYXS shares in the last 24 months: Lara Sullivan ($70,146.10), and Mark Chin ($5,324,571.05).Pyxis Oncology has a twelve month low of $1.10 and a twelve month high of $6.92. The business has a fifty day moving average of $1.71 and a 200-day moving average of $2.30. Pyxis Oncology ( NASDAQ:PYXS – Get Free Report) last released its earnings results on Tuesday, November 7th. The company reported ($0.56) earnings per share for …Pyxis Oncology, Inc. $ 1.625000 $ 0.06 (3.50%) Trade Now Your capital is at risk. Other fees may apply. Overview Brokers News Prediction Dividend Earnings Pyxis …1Y 2.0% Updated 26 Nov, 2023 Data Company Financials + 3 Analysts PYXS Stock Overview Pyxis Oncology, Inc., a clinical-stage biopharmaceutical company, …

321 Harrison Avenue 11 th Floor, Suite 1 Boston, MA 02118 (617) 453-3596 | [email protected]

On average, Wall Street analysts predict. that Pyxis Oncology's share price could reach $8.67 by Nov 30, 2024. The average Pyxis Oncology stock price prediction forecasts a potential upside of 445.09% from the current PYXS share price of $1.59.

Real time Pyxis Oncology (PYXS) stock price quote, stock graph, news & analysis.Pyxis Oncology, Inc. $ 1.625000 $ 0.06 (3.50%) Trade Now Your capital is at risk. Other fees may apply. Overview Brokers News Prediction Dividend Earnings Pyxis …Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer 2023-11-07T16:30:37 Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate UpdatePyxis Stock Is Up 170% This Week. How Much Higher Can It Go? TipRanks March 30, 2023 at 2:16 PM · 2 min read It’s been a good week for investors of Pyxis …Dr. Kobayashi brings over 25 years of experience in oncology drug development, including Antibody Drug Conjugates (ADCs) and other oncology …Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for Pyxis Oncology stock is $12, which predicts an increase of …

Pyxis Oncology, Inc NASDAQ: PYXS is a preclinical oncology company focused on developing a range of therapeutics to treat cancers. The Company has developed ...Oncology Pharma's stock was trading at $0.3386 at the beginning of the year. Since then, ONPH shares have decreased by 99.9% and is now trading at $0.0002. View the best growth stocks for 2023 here.Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing.The current price Pyxis Oncology ( PYXS) is trading at is $1.51, which is within the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. Analysts publish ratings ...Welcome to Predictive Oncology The leading edge of a new frontier in drug discovery Integrating scientific rigor with machine learning • Overcoming challenges of clinical trials • Improving the probability of success • Collaborating with partners in biopharma • Advancing molecules to medicine with confidence and accuracy Connect with us Changing the …Pyxis Oncology Home Weeks bring all of our colleagues together at our headquarters on a regularly scheduled basis to engage on key topics face-to-face while fostering a constructive and vibrant community. We are leveraging state-of-the-art technology to ensure seamless interactions among our employees and facilitate global collaboration with ...Price Target Based on short-term price targets offered by four analysts, the average price target for Pyxis Oncology, Inc. comes to $7.25. The forecasts range from a low of $2.00 to a high of...

As of August 15, 2022, the outstanding number of shares of Common Stock of Pyxis Oncology was 32,834,561. About Pyxis Oncology, Inc. Pyxis Oncology, Inc. is an oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. By leveraging our fully ...Pyxis Oncology Inc (PYXS) stock is higher by 8.35% while the S&P 500 has fallen -0.1% as of 11:49 AM on Monday, Apr 3. PYXS is higher by $0.33 from the previous closing price of $4.01 on volume of 6,295,868 shares. Over the past year the S&P 500 is down -10.42% while PYXS is higher by 21.17%. PYXS lost -$3.65 per share the over the last 12 months.

As of June 30, 2023, the outstanding number of shares of common stock of Pyxis Oncology was 39,376,941. About Pyxis Oncology, Inc. Pyxis Oncology, Inc. is a clinical-stage company focused on ...Tesla’s stock is predicted to increase in value in 2015, according to Forbes. In January 2015, Forbes noted that Tesla Motors, Inc.March 30, 2023 at 2:16 PM · 2 min read. It’s been a good week for investors of Pyxis Oncology ( NASDAQ:PYXS), to say the least. Over the past 4 sessions Pyxis shares have gained 170%, bringing ...Nov 30, 2023 · High Growth Earnings: PYXS is forecast to remain unprofitable over the next 3 years. Revenue vs Market: PYXS's revenue (66.6% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: PYXS's revenue (66.6% per year) is forecast to grow faster than 20% per year. The Predictive Oncology Inc stock price gained 2.03% on the last trading day (Friday, 24th Nov 2023), rising from $2.95 to $3.01. During the last trading day the stock fluctuated 6.77% from a day low at $2.84 to a day high of $3.03. The price has fallen in 7 of the last 10 days and is down by -10.68% for this period.Zacks Investment Research is releasing its prediction for PYXS based on the 1-3 month trading system that more than doubles the S&P 500. ... to Get Acquired by Pyxis Oncology, Stock Up 05/25/23-2 ... Detailed statistics for Pyxis Oncology, Inc. (PYXS) stock, including valuation metrics, financial numbers, share information and more. Skip to main content. Log In Free Trial. ... The beta is 1.12, so Pyxis Oncology's price volatility has been higher than the market average. Beta (1Y) 1.12: 52-Week Price Change +0.66%: 50-Day Moving …The Polestar Automotive Holding UK PLC stock price gained 1.96% on the last trading day (Tuesday, 28th Nov 2023), rising from $2.04 to $2.08. During the last trading day the stock fluctuated 5.05% from a day low at $1.98 to a day high of $2.08. The price has risen in 7 of the last 10 days and is up by 0.48% over the past 2 weeks.

View the latest Pyxis Oncology Inc. (PYXS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

GRTS: Get the latest Gritstone Oncology stock price and detailed information including GRTS news, historical charts and realtime prices. Indices Commodities Currencies Stocks

Find the latest analyst research for Pyxis Oncology, Inc. Common Stock (PYXS) at Nasdaq.com.Feb 13, 2023 · As of February 13, 2023, the average one-year price target for Pyxis Oncology is $11.22. The forecasts range from a low of $4.04 to a high of $16.80. The average price target represents an ... 0.73%. $39.94B. Astellas Pharma Inc. -4.37%. ¥3.42T. PYXS | Complete Pyxis Oncology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. As of September 30, 2023, the outstanding number of shares of common stock of Pyxis Oncology was 44,294,092. About Pyxis Oncology, Inc. Pyxis Oncology, Inc. is a clinical-stage company focused on ...Pyxis Oncology, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody, which is in Phase 1 clinical trial for the treatment of solid tumors, including non-small cell lung cancer (NSCLC) without driver ...A high-level overview of Pyxis Oncology, Inc. (PYXS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. May 30, 2023 at 5:30 AM · 6 min read. Pyxis Oncology. First subject dosed in Phase 1 trial of PYX-106, a fully human immunotherapy antibody candidate. Second dose level initiated in Phase 1 trial ...Nov 29, 2023 · See the latest Pyxis Oncology Inc stock price (PYXS:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Pyxis Oncology continues to advance lead programs ... the outstanding number of shares of Common Stock of Pyxis Oncology was 35,097,256. ... and it is not possible for our management to predict ...The transportation company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. The transportation company had revenue of $11.10 million for the quarter. Pyxis Tankers had a trailing twelve-month return on equity of 30.88% and a net margin of 43.32%.Pyxis Oncology Inc (US:PYXS) has 85 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9,214,235 shares. Largest shareholders include Laurion Capital Management LP, Vanguard Group Inc, VTSMX - Vanguard Total Stock Market Index …Pyxis Oncology Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... IV is a forward looking prediction of the likelihood of price change of the underlying asset, with a higher IV signifying that the market expects significant price movement, and a lower IV signifying the ...

The stock price has increased by +0.66% in the last 52 weeks. The beta is 1.12, so Pyxis Oncology's price volatility has been higher than the market average. Beta (1Y)The current price Pyxis Oncology ( PYXS) is trading at is $1.51, which is within the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. Analysts publish ratings ...Earnings for Pyxis Oncology are expected to grow in the coming year, from ($2.01) to ($1.57) per share. Pyxis Oncology has not formally confirmed its next …Instagram:https://instagram. hvac stockbest stock under 20yieldmax etfshow to become a day trader at home Milestone marks transition of Pyxis Oncology to a clinical-stage company . Preliminary data anticipated in early 2024. CAMBRIDGE, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today … how to invest in indiacrsb Pyxis Oncology, Inc. (PYXS) Stock Price, Quote & News - Stock Analysis 1.59 +0.04 (2.25%) At close: Nov 30, 2023, 4:00 PM 1.64 +0.05 (3.14%) After-hours: Nov 30, 2023, 5:54 PM EST Overview Financials Statistics No 1Y chart data available About PYXS short term medical insurance utah As of September 30, 2023, the outstanding number of shares of common stock of Pyxis Oncology was 44,294,092. About Pyxis Oncology, Inc. Pyxis Oncology, Inc. is a clinical-stage company focused on ...May 12, 2023 · Pyxis Oncology Inc (PYXS) stock is up 9.87% while the S&P 500 is lower by -0.69% as of 2:04 PM on Friday, May 12. PYXS has risen $0.30 from the previous closing price of $3.04 on volume of 1,647,588 shares. Over the past year the S&P 500 has risen 4.24% while PYXS has risen 57.55%. PYXS lost -$3.65 per share in the over the last 12 months. Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing.